• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从 2000 年到 2022 年 MAFLD 炎症与纤维化的研究:文献计量分析。

Study on inflammation and fibrogenesis in MAFLD from 2000 to 2022: a bibliometric analysis.

机构信息

Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

College of Art and Sciences, Washington University in St. Louis, St. Louis, MO, United States.

出版信息

Front Endocrinol (Lausanne). 2023 Aug 31;14:1231520. doi: 10.3389/fendo.2023.1231520. eCollection 2023.

DOI:10.3389/fendo.2023.1231520
PMID:37720529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10500306/
Abstract

Chronic inflammation and fibrosis are significant factors in the pathogenesis of metabolic-associated fatty liver disease (MAFLD). In this study, we conducted a bibliometric analysis of publications on inflammation and fibrogenesis in MAFLD, with a focus on reporting publication trends. Our findings indicate that the USA and China are the most productive countries in the field, with the University of California San Diego being the most productive institution. Over the past 23 years, Prof. Diehl AM has published 25 articles that significantly contributed to the research community. Notably, the research focus of the field has shifted from morbid obesity and adiponectin to metabolic syndrome, genetics, and microbiome. Our study provides a comprehensive and objective summary of the historical characteristics of research on inflammation and fibrogenesis in MAFLD, which will be of interest to scientific researchers in this field.

摘要

慢性炎症和纤维化是代谢相关脂肪性肝病(MAFLD)发病机制中的重要因素。在这项研究中,我们对 MAFLD 炎症和纤维化相关出版物进行了文献计量学分析,重点报告了发表趋势。我们的研究结果表明,美国和中国是该领域最具成果的国家,加利福尼亚大学圣地亚哥分校是最具成果的机构。在过去的 23 年中,Diehl AM 教授发表了 25 篇文章,为该研究领域做出了重要贡献。值得注意的是,该领域的研究重点已经从病态肥胖和脂联素转移到代谢综合征、遗传学和微生物组。本研究全面客观地总结了 MAFLD 炎症和纤维化研究的历史特征,这将引起该领域科学研究人员的兴趣。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29c/10500306/13fda664ddff/fendo-14-1231520-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29c/10500306/b35a04d3c591/fendo-14-1231520-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29c/10500306/340b9f2f95d4/fendo-14-1231520-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29c/10500306/b0ef741dc5bf/fendo-14-1231520-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29c/10500306/08b3af1961b2/fendo-14-1231520-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29c/10500306/6461d2f8de9c/fendo-14-1231520-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29c/10500306/0a35b87e9c4a/fendo-14-1231520-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29c/10500306/11585e60ff1e/fendo-14-1231520-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29c/10500306/13fda664ddff/fendo-14-1231520-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29c/10500306/b35a04d3c591/fendo-14-1231520-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29c/10500306/340b9f2f95d4/fendo-14-1231520-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29c/10500306/b0ef741dc5bf/fendo-14-1231520-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29c/10500306/08b3af1961b2/fendo-14-1231520-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29c/10500306/6461d2f8de9c/fendo-14-1231520-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29c/10500306/0a35b87e9c4a/fendo-14-1231520-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29c/10500306/11585e60ff1e/fendo-14-1231520-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d29c/10500306/13fda664ddff/fendo-14-1231520-g008.jpg

相似文献

1
Study on inflammation and fibrogenesis in MAFLD from 2000 to 2022: a bibliometric analysis.从 2000 年到 2022 年 MAFLD 炎症与纤维化的研究:文献计量分析。
Front Endocrinol (Lausanne). 2023 Aug 31;14:1231520. doi: 10.3389/fendo.2023.1231520. eCollection 2023.
2
Emerging trends and hotspots in metabolic dysfunction-associated fatty liver disease (MAFLD) research from 2012 to 2021: A bibliometric analysis.2012 年至 2021 年代谢功能障碍相关脂肪性肝病(MAFLD)研究的新兴趋势和热点:文献计量分析。
Front Endocrinol (Lausanne). 2023 Jan 24;14:1078149. doi: 10.3389/fendo.2023.1078149. eCollection 2023.
3
Emerging trends and hotspots in the links between the gut microbiota and MAFLD from 2002 to 2021: A bibliometric analysis.2002 年至 2021 年肠道微生物群与 MAFLD 之间关联的新兴趋势和热点:文献计量分析。
Front Endocrinol (Lausanne). 2022 Oct 13;13:990953. doi: 10.3389/fendo.2022.990953. eCollection 2022.
4
Emerging trends and hotspots in the links between the bile acids and NAFLD from 2002 to 2022: A bibliometric analysis.2002 年至 2022 年胆汁酸与非酒精性脂肪性肝病相关性的研究趋势和热点:文献计量分析。
Endocrinol Diabetes Metab. 2024 Jan;7(1):e460. doi: 10.1002/edm2.460. Epub 2023 Nov 8.
5
Global publication trends and research hotspots of the gut-liver axis in NAFLD: A bibliometric analysis.非酒精性脂肪性肝病(NAFLD)肠道-肝脏轴的全球发表趋势和研究热点:文献计量分析。
Front Endocrinol (Lausanne). 2023 Mar 9;14:1121540. doi: 10.3389/fendo.2023.1121540. eCollection 2023.
6
Correlation of the pediatric metabolic index with NAFLD or MAFLD diagnosis, and serum adipokine levels in children.儿童代谢指数与儿童非酒精性脂肪性肝病或代谢相关脂肪性肝病诊断的相关性,以及血清脂肪因子水平。
Clin Res Hepatol Gastroenterol. 2023 May;47(6):102137. doi: 10.1016/j.clinre.2023.102137. Epub 2023 May 5.
7
Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study.代谢相关脂肪性肝病可提高肝硬度检测的检出率:鹿特丹研究。
Hepatology. 2022 Feb;75(2):419-429. doi: 10.1002/hep.32131. Epub 2021 Dec 13.
8
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research.代谢(功能障碍)相关脂肪性肝病指标及其对肝脏研究的贡献。
Hepatol Int. 2024 Dec;18(6):1740-1755. doi: 10.1007/s12072-024-10731-0. Epub 2024 Oct 16.
9
Prevalence and characteristics of MAFLD in Chinese adults aged 40 years or older: A community-based study.中国 40 岁及以上成年人 MAFLD 的患病率及特征:一项基于社区的研究。
Hepatobiliary Pancreat Dis Int. 2022 Apr;21(2):154-161. doi: 10.1016/j.hbpd.2022.01.006. Epub 2022 Jan 31.
10
Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease.与代谢功能障碍相关的脂肪性肝病比非酒精性脂肪性肝病能更好地识别出具有心血管疾病风险的受试者。
Liver Int. 2023 Mar;43(3):608-625. doi: 10.1111/liv.15508. Epub 2023 Jan 11.

引用本文的文献

1
Diagnostic accuracy of Fatty Liver Index (FLI) for detecting Metabolic Associated Fatty Liver Disease (MAFLD) in adults attending a tertiary care hospital, a cross-sectional study.一项横断面研究:三级医院成年患者中脂肪肝指数(FLI)检测代谢相关脂肪性肝病(MAFLD)的诊断准确性
Clin Diabetes Endocrinol. 2024 Dec 13;10(1):46. doi: 10.1186/s40842-024-00197-2.
2
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research.代谢(功能障碍)相关脂肪性肝病指标及其对肝脏研究的贡献。
Hepatol Int. 2024 Dec;18(6):1740-1755. doi: 10.1007/s12072-024-10731-0. Epub 2024 Oct 16.
3
Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact.

本文引用的文献

1
Ishige okamurae Celluclast extract ameliorates non-alcoholic fatty liver in high-fructose diet-fed mice by modulation of lipid metabolism and gut microbiota composition.冈村氏石莼纤维素酶提取物通过调节脂质代谢和肠道微生物群组成改善高果糖饮食喂养小鼠的非酒精性脂肪肝。
Food Chem Toxicol. 2023 Jul;177:113864. doi: 10.1016/j.fct.2023.113864. Epub 2023 May 30.
2
Emerging pharmacological treatment options for MAFLD.非酒精性脂肪性肝病(MAFLD)新出现的药物治疗选择
Ther Adv Endocrinol Metab. 2022 Dec 10;13:20420188221142452. doi: 10.1177/20420188221142452. eCollection 2022.
3
Association of metabolic dysfunction-associated fatty liver disease, type 2 diabetes mellitus, and metabolic goal achievement with risk of chronic kidney disease.
肠道微生物群和免疫细胞在代谢相关脂肪性肝病中的作用:临床影响。
Hepatol Int. 2024 Oct;18(Suppl 2):861-872. doi: 10.1007/s12072-024-10674-6. Epub 2024 Jul 12.
4
Mapping global research trends: Nutrition associations with nonalcoholic fatty liver disease - a Scopus bibliometric analysis.绘制全球研究趋势图:营养与非酒精性脂肪性肝病的关联——Scopus 文献计量分析。
World J Gastroenterol. 2024 Jun 28;30(24):3106-3119. doi: 10.3748/wjg.v30.i24.3106.
5
Evolutive Models, Algorithms and Predictive Parameters for the Progression of Hepatic Steatosis.肝脂肪变性进展的演变模型、算法及预测参数
Metabolites. 2024 Apr 3;14(4):198. doi: 10.3390/metabo14040198.
代谢相关脂肪性肝病、2 型糖尿病及其代谢目标达标与慢性肾脏病风险的相关性。
Front Public Health. 2022 Nov 7;10:1047794. doi: 10.3389/fpubh.2022.1047794. eCollection 2022.
4
Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD.反应性氧物种与代谢相关脂肪性肝病发病机制中的氧化应激
J Clin Transl Hepatol. 2022 Oct 28;10(5):939-946. doi: 10.14218/JCTH.2022.00067. Epub 2022 Jul 6.
5
Current perspectives and trend of nanomedicine in cancer: A review and bibliometric analysis.纳米医学在癌症治疗中的当前观点与趋势:综述与文献计量分析
J Control Release. 2022 Dec;352:211-241. doi: 10.1016/j.jconrel.2022.10.023. Epub 2022 Oct 21.
6
Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- κB signaling pathways.金诺芬通过 NRF2 和 NF-κB 信号通路减轻非酒精性脂肪性肝病的肝脂肪变性和肝纤维化。
Clin Mol Hepatol. 2022 Oct;28(4):827-840. doi: 10.3350/cmh.2022.0068. Epub 2022 Jun 22.
7
Interaction effect between NAFLD severity and high carbohydrate diet on gut microbiome alteration and hepatic lipogenesis.非酒精性脂肪性肝病严重程度和高碳水化合物饮食对肠道微生物组改变和肝内脂质生成的交互作用。
Gut Microbes. 2022 Jan-Dec;14(1):2078612. doi: 10.1080/19490976.2022.2078612.
8
Endoplasmic reticulum stress in nonalcoholic (metabolic associated) fatty liver disease (NAFLD/MAFLD).内质网应激与非酒精性(代谢相关)脂肪性肝病(NAFLD/MAFLD)。
J Cell Biochem. 2022 Oct;123(10):1585-1606. doi: 10.1002/jcb.30247. Epub 2022 May 1.
9
LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver.基于 LC-MS 的脂质组学分析在鉴别非酒精性脂肪性肝炎与非酒精性脂肪肝患者中的应用。
Hepatobiliary Pancreat Dis Int. 2021 Oct;20(5):452-459. doi: 10.1016/j.hbpd.2021.05.008. Epub 2021 Jun 25.
10
Role of Insulin Resistance in MAFLD.胰岛素抵抗在 MAFLD 中的作用。
Int J Mol Sci. 2021 Apr 16;22(8):4156. doi: 10.3390/ijms22084156.